Adenocarcinoma of the esophagogastric junction

Digestive Diseases

Volumn 17, Issue 3, 1999, Pages 153-162

  Jenkins, Timothy D ^a   Friedman, Lawrence S ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Esophagogastric junction; Intestinal metaplasia

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER STAGING; CLINICAL TRIAL; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0032785106     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016920     Document Type: Review

References (80)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-1289.
2. Yang PC, Davis S: Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. Int J Epidemiol 1988;17:293-297.
3. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophagcal and gastric carcinoma in the United States. Cancer 1988; 83:2049-2053.
4. Blot WJ: Esophageal cancer trends and risk factors. Semin Oncol 1994;21:403-410.
5. Blot WJ, Devesa SS, Fraumeni JF Jr: Continuing climb in rates of esophageal adenocarcinoma: An update. JAMA 1993;270:1320.
6. Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, Ancona E, Peracchia A: Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 1997;10: 190-195.
7. Morales TG: Adenocarcinoma of the gastric cardia. Dig Dis 1997;15:346-356.
8. Kalish RJ, Clancy PE, Orringer MB, Appelman HD: Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology 1984;86:461-467.
9. Siewert JR, Stein HJ: Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85:1457-1459.
10. Kahrilas PJ: Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin North Am 1997;26:467-486.
11. Spechler SJ: Short and ultrashort Barrett's esophagus What does it mean? Semin Gastrointest Dis 1997;8:59-67.
12. Cameron AJ: Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-494.
13. Clark GWB, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG: Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg 1997; 1:113-122.
14. Spechler SJ: The columnar lined oesophagus: A riddle wrapped in a mystery inside an enigma. Gut 1997;41:710-711.
15. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE: Squamous islands in Barrett's esophagus: What lies underneath? Am J Gastroenterol 1998;93:332-335.
16. Ortiz-Hidalgo C, De La Vega G, Aguirre-Garcia J: The histopathology and biologic prognostic factors of Barrett's esophagus: A review. J Clin Gastroenterol 1998;26:324-333.
17. Gimenez A, Minguela A, Parrilla P, Bermejo J, Perez D, Molina J, Garcia AM, Ortiz MA, Alvarez R, de Haro LM: Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with Barrett's esophagus. Cancer 1998;83:641-651.
18. Regalado SP, Nambu Y, Iannettoni MD, Orringer MB, Beer DG: Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Mol Carcinog 1998;22:182-189.
19. MacDonald WC, MacDonald JB: Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 1987;60:1094-1098
20. Sarbia M, Borchard F, Hengels KJ: Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study. Pathol Res Pract 1993;189:530-535.
21. Aikou T, Shimazu H: Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 1989;219:290-295.
22. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA: Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-589.
23. Rios-Castellanos E, Sitas F, Shepherd NA, Jewell DP: Changing pattern of gastric cancer in Oxfordshire. Gut 1992;33:1312-1317.
24. Fein M, Fuchs KH, Ritter MP, Freys SM, Heimbucher J, Staab C, Thiede A: Application of the new classification for cancer of the cardia. Surgery 1998;124:707-714.
25. Isolauri J, Laippala P: Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
26. Bosch A, Frias Z, Caldwell WL: Adenocarcinoma of the esophagus. Cancer 1979;43:1557-1561.
27. Golematis B, Tzardis P, Hatzikostas P, Papadimitriou K, Haritopoulos N: Changing pattern of distribution of carcinoma of the stomach. Br J Surg 1990;77:63-64.
28. Salvon-Harman JC, Cady B, Nikulasson S, Khettry U, Stone MD, Lavin P: Shifting proportions of gastric adenocarcinomas. Arch Surg 1994;129:381-389.
29. Zhang ZF, Kurtz RC, Sun M, Karpeh M Jr, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S: Adenocarcinomas of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996;5:761-768.
30. Romero Y, Cameron AJ, Locke GR 3rd, Schaid DJ, Slezak JM, Branch CD, Melton LJ 3rd: Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 1997; 113:1449-1456.
31. Khan SM, Pillay SP, Papadimos D, Yong JW, Roberts HJ, Crawford DH: A technique for the culture of Barrett's oesophageal cells [published erratum appears in J Gastroenterol Hepatol 1997;12:84]. J Gastroenterol Hepatol 1997;12: 606-611.
32. Menke-Pluymers MB, van Drunen E, Vissers KJ, Mulder AH, Tilanus HW, Hagemeijer A: Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet 1996;90:109-117.
33. Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR: Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998;153:287-294.
34. Sarbia M, Molsberger G, Willers R, Horstmann O, Schroders C, Porschen R, Gabbert HE: The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction. J Cancer Res Clin Oncol 1996;122:186-188.
35. Petty EM, Kalikin LM, Orringer MB, Beer DG: Distal chromosome 17q loss in Barrett's esophageal and gastric cardia adenocarcinomas: Implications for tumorigenesis. Mol Carcinog 1998;22:222-228.
36. Moskaluk CA, Heitmiller R, Zahurak M, Schwab D, Sidransky D, Hamilton SR: p53 and p21(WAF1/CIP1/SDH) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol 1996;27:1211-1220.
37. Meltzer SJ, Yin J, Manin B, Rhyu MG, Cottrell J, Hudson E, Redd JL, Krasna MJ, Abraham JM, Reid BJ: Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res 1994;354: 3379-3382.
38. Jiricny J: Replication errors: Cha(lle)nging the genome. EMBO J 1998;17:6427-6436.
39. Zhang ZF, Kurtz RC, Marshall JR: Cigarette smoking and esophageal and gastric cardia adenocarcinoma. J Natl Cancer Inst 1997;89: 1247-1249.
40. Gray JR, Coidman AJ, MacDonald WC: Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer 1992;69:2227-22311.
41. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan IL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr: Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997;89:1277-1284.
42. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr: Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150-155.
43. Zhang ZF, Kurtz RC, Yu GP, Sun M, Gargon N, Karpeh M Jr, Fein JS, Harlap S: Adenocarcinomas of the esophagus and gastric cardia: The role of diet. Nutr Cancer 1997;327:298-309.
44. Quddus MR, Henley JD, Sulaiman RA, Palumbo TC, Gnepp DR: Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus. Hum Pathol 1997;28:1007-1009.
45. Wright TA, Myskow M, Kingsnorth AN: Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis Esophagus 1997;10:196-200.
46. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr: An inverse relation between cagA + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-590.
47. Richter JE, Falk GW, Vaezi MF: Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am J Gastroenterol 1998;93:1800-1882.
48. Genta RM, Huberman RM, Graham DY: The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-199.
49. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK: Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 1999;116:277-285.
50. Hansson LR, Engstrand L, Nyren O, Lindgren A: Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885-888.
51. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-1131.
52. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ: Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83:1734-1739.
53. Wu MS, Chen SY, Shun CT, Lee WJ, Wang HP, Wang TH, Chen CJ, Lin JT: Increased prevalence of Helicobacter pylori infection among patients affected with intestinal-type gastric cancer at non-cardiac locations. J Gastroenterol Hepatol 1997;12:425-428.
54. Erkisi M, Colakoglu S, Koksal F, Tuncer I, Burgut R, Karakose H, Doran F, Zorludemir S: Relationship of Helicobacter pylori infection to several malignant and non-malignant gastrointestinal diseases. J Exp Clin Cancer Res 1997; 16:289-293.
55. Debongnie JC, Burette A, Glupczynski Y, De Prez C, De Koninck X, Donnay M: Helicobacter pylori and gastric cancer. An endoscopic series. Acta Gastroenterol Belg 1997;60:189-1991.
56. Siman JH, Forsgren A, Berglund G, Floren CH: Association between Helicobacter pylori and gastric carcinoma in the city of Malmo, Sweden. A prospective study. Scand J Gastroenterol 1997;32:1215-1221.
57. Vaughan IL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF Jr: Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev 1998;7:749-756.
58. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrovv R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ: Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
59. Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Winawer SJ, Urmacher C, Brennan MF: Preoperative staging of gastric cancer: Comparison of endoscopic US and dynamic CT. Radiology 1991;181:426-432.
60. Witt TR, Bains MS, Zaman MB, Martini N: Adenocarcinoma in Barrett's esophagus. J Thorac Cardiovasc Surg 1983;85:337-345.
61. Van Dam J: Endosonographic evaluation of the patient with esophageal cancer. Chest 1997; 112(suupl):184-190.
62. Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T: Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 1996;111:85-95.
63. Lee RB, Miller JI: Esophagectomy for cancer. Surg Clin North Am 1997;77:1169-1196.
64. Ellis FH Jr, Heatley GJ, Krasna MJ, Williamson WA, Balogh K: Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1947;113:836-848.
65. Matsubara I, Ueda M, Yanagida O, Nakajima I, Nishi M: How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg 1994;107:1073-1078.
66. Stahl M, Vanhoefer U, Stuschke M, Walz MK, Muller C, Wilke H: Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. Eur J Cancer 1998;34:668-673.
67. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
68. Kelsen DP, Ginsberg R, Pajak IF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;139:1979-1984.
69. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
70. Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A, Watson M, Hill AS, Nicolson MC, O'Brien ME, Evans IC, Nicolson V: Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival. Cancer 1996;77:1978-1985.
71. Webb A, Cnnningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997;15:261-267.
72. Vaughn DJ, Meropol NJ, Holroyde C, Mintzer D, Nuamah I, Armstead B, Douglass HO Jr, Hailer DG: A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program Trial. Am J Clin Oncol 1997;20:242-246.
73. Kelsen D, Lovett D, Wong J, Saltz L, Buckley M, Murray P, Heelan R, Lightdale C: Interferon alta-2a and fluorouracil in the treatment of patients with advanced esophageal cancer. J Clin Oncol 1992;10:269-274.
74. Stahl M, Wilke H, Meyer HJ, Preusser P, Berns I, Fink U, Achterrath W, Knipp H, Harstrick A, Berger M, et al: 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer 1994;30A:325-328.
75. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP: Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994;86:1086-1091.
76. Ponce RJ, Kimmey MB: Endoscopic therapy of esophageal cancer. Surg Clin North Am 1997; 77:1197-1217.
77. Endo M: Endoscopic resection as local treatment of mucosal cancer of the esophagus. Endoscopy 1993;25:672-674.
78. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, Ell C: Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-455.
79. Sampliner RE: Adenocarcinoma of the esophagus and gastric cardia: Is there progress in the face of increasing cancer incidence? Ann Intern Med 1999;130:67-69.
80. Clark GW, Smyrk TC, Mirvish SS, Anselmino M, Yamashita Y, Hinder RA, DeMeester TR, Birt DF: Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: An experimental rat model. Ann Surg Oncol 1994;1:252-261.